Shanghai, China

Tao Yu

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal4 out of 121 
 
Shanghai Huahong Grace Semiconductor Manufacturing Corporation
 patents
silverMedal2 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
bronzeMedal2 out of 65 
 
Medshine Discovery Inc.
 patents
41 out of 1 
 
Fuijan Cosunter Pharmaceutical Co. Ltd.
 patent
51 out of 1 
 
Shenzhen Salubris Pharm Co Ltd.
 patent
61 out of 1 
 
China Automotive Innovation Co., Ltd
 patent
71 out of 1 
 
Shanghai Uni-sentry Intelligent Technology Co., Ltd.
 patent
81 out of 65 
 
East China Normal University
 patents
91 out of 1 
 
Hangzhou Sciwind Biosciences Co., Ltd
 patent
101 out of 7 
 
Fujian Akeylink Biotechnology Co., Ltd.
 patents
111 out of 3 
 
Huaqin Technology Co., Ltd.
 patents
121 out of 1 
 
Shenyang Machine Tool (group) Research & Design Institute Co., Ltd. Shanghai Branch
 patent
131 out of 5 
 
Cisen Pharmaceutical Co., Ltd.
 patents
141 out of 2 
 
Qingdao Huanghai Pharmaceutical Co., Ltd.
 patents
151 out of 1 
 
A & H International Cosmetics Co., Ltd
 patent
161 out of 1 
 
Dongbao Purple Star (hangzhou) Biopharmaceutical Co., Ltd.
 patent
171 out of 3 
 
D3 Bio (wuxi) Co., Ltd.
 patents
181 out of 5 
 
Cgenetech (suzhou, China) Co., Ltd.
 patents
192 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2016-2025

where 'Filed Patents' based on already Granted Patents

22 patents (USPTO):

Title: The Innovative Contributions of Tao Yu in Pharmaceutical Science

Introduction: Tao Yu, an accomplished inventor based in Shanghai, China, has made significant strides in the realm of pharmaceuticals with a remarkable portfolio comprising 20 patents. His innovative work stands at the intersection of chemistry and medicine, showcasing a strong commitment to advancing healthcare solutions through his dedicated research and development.

Latest Patents: Among his notable inventions, the "SGLTS/DPP4 inhibitor and application thereof" stands out as a significant advancement. This patent details a class of compounds functioning as a triple inhibitor for SGLT1, SGLT2, and DPP4, potentially serving as a groundbreaking drug preparation method. The innovation specifically involves compounds represented by formula (I), including their isomers and pharmaceutically acceptable salts. Furthermore, Tao has contributed to the preparation method for a powder product, which combines specific proportions of oil-phase and water-phase components to facilitate the creation of a powder base product. This novel powder, after undergoing a meticulous freeze-drying process, boasts enhanced characteristics, such as reduced cakey makeup and a lighter skin feel, improving its applicability in the cosmetics and pharmaceutical industries.

Career Highlights: Tao Yu has accrued valuable experience through his tenure at prominent companies including Shanghai Huahong Grace Semiconductor Manufacturing Corporation and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His roles at these organizations have enabled him to refine his expertise in the fields of drug formulation and pharmaceutical manufacturing.

Collaborations: Throughout his career, Tao has collaborated with esteemed colleagues, including Chengde Wu and Shuhui Chen. This teamwork has fostered an exchange of ideas and has propelled many innovative projects forward, reinforcing the significance of collaborative effort in driving scientific advancements.

Conclusion: Tao Yu exemplifies the impact of innovation in the pharmaceutical sector. His impressive portfolio of patents and commitment to developing effective healthcare solutions highlights the importance of creativity and collaboration in driving progress. As he continues to push the boundaries of pharmaceutical science, Tao’s contributions are poised to make lasting impacts on the industry and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…